Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.

Allan B, Davis J, Perez E, Lew J, Sola J.

Eur J Pediatr Surg. 2013 Oct;23(5):394-9. doi: 10.1055/s-0033-1333643. Epub 2013 Feb 26.

PMID:
23444065
2.

Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.

Navalkele P, O'Dorisio MS, O'Dorisio TM, Zamba GK, Lynch CF.

Pediatr Blood Cancer. 2011 Jan;56(1):50-7. doi: 10.1002/pbc.22559.

3.

Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients.

Perez EA, Gutierrez JC, Koniaris LG, Neville HL, Thompson WR, Sola JE.

J Pediatr Surg. 2009 Jan;44(1):197-203. doi: 10.1016/j.jpedsurg.2008.10.039.

PMID:
19159743
4.

Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.

Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE.

J Surg Res. 2009 Sep;156(1):167-72. doi: 10.1016/j.jss.2009.03.098. Epub 2009 May 8.

PMID:
19631341
5.

Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?

Fitzgerald TL, Dennis SO, Kachare SD, Vohra NA, Zervos EE.

Surgery. 2015 Aug;158(2):466-71. doi: 10.1016/j.surg.2015.03.042. Epub 2015 May 23.

PMID:
26013986
6.

Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.

Kuo EJ, Salem RR.

Ann Surg Oncol. 2013 Sep;20(9):2815-21. doi: 10.1245/s10434-013-3005-7. Epub 2013 Jun 15.

PMID:
23771245
7.

Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.

Caldarella A, Crocetti E, Paci E.

Pathol Oncol Res. 2011 Sep;17(3):759-63. doi: 10.1007/s12253-011-9382-y. Epub 2011 Apr 9.

PMID:
21476126
8.

An analysis of 73 cases of pediatric malignant tumors of the thymus.

Allan BJ, Thorson CM, Davis JS, Van Haren RM, Parikh PP, Perez EA, Lew JI, Sola JE.

J Surg Res. 2013 Sep;184(1):397-403. doi: 10.1016/j.jss.2013.03.020. Epub 2013 Mar 29.

PMID:
23570972
9.

Malignant pancreatic tumors in children and young adults: evaluation of 228 patients identified through the Surveillance, Epidemiology, and End Result (SEER) database.

Brecht IB, Schneider DT, Klöppel G, von Schweinitz D, Barthlen W, Hamre MR.

Klin Padiatr. 2011 Nov;223(6):341-5. doi: 10.1055/s-0031-1287836. Epub 2011 Oct 19.

PMID:
22012608
10.

A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.

Modlin IM, Champaneria MC, Chan AK, Kidd M.

Am J Gastroenterol. 2007 Jul;102(7):1464-73. Epub 2007 Mar 27.

PMID:
17391319
11.

Childhood cancer among Alaska Natives.

Lanier AP, Holck P, Ehrsam Day G, Key C.

Pediatrics. 2003 Nov;112(5):e396.

PMID:
14595083
12.

Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004.

Alsina M, Marcos-Gragera R, Capdevila J, Buxó M, Ortiz RM, Barretina P, Vilardell L, Brunet J, Beltran M, Izquierdo Á.

Cancer Epidemiol. 2011 Dec;35(6):e49-54. doi: 10.1016/j.canep.2011.05.011. Epub 2011 Aug 16.

PMID:
21840785
13.

Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.

Metildi C, McLemore EC, Tran T, Chang D, Cosman B, Ramamoorthy SL, Saltzstein SL, Sadler GR.

Am Surg. 2013 Oct;79(10):1068-74.

14.

Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications.

Waxweiler TV, Rusthoven CG, Proper MS, Cost CR, Cost NG, Donaldson N, Garrington T, Greffe BS, Heare T, Macy ME, Liu AK.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):339-48. doi: 10.1016/j.ijrobp.2015.02.007.

PMID:
25968827
15.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB.

J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. Review.

PMID:
18565894
16.

Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study.

McAteer JP, Huaco JA, Gow KW.

J Pediatr Surg. 2013 May;48(5):1025-31. doi: 10.1016/j.jpedsurg.2013.02.017.

PMID:
23701777
17.

Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.

Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S.

Cancer. 2015 Feb 15;121(4):589-97. doi: 10.1002/cncr.29099. Epub 2014 Oct 13.

18.

Incidence and outcomes of malignant pediatric lung neoplasms.

Neville HL, Hogan AR, Zhuge Y, Perez EA, Cheung MC, Koniaris LG, Thompson WR, Sola JE.

J Surg Res. 2009 Oct;156(2):224-30. doi: 10.1016/j.jss.2009.03.100. Epub 2009 May 13.

PMID:
19631347
19.

Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.

Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A.

J Clin Oncol. 2009 Jul 10;27(20):3391-7. doi: 10.1200/JCO.2008.19.7483. Epub 2009 Apr 27.

PMID:
19398574
20.

Small intestinal neuroendocrine tumors: prognostic factors and survival.

Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E.

Scand J Gastroenterol. 2009;44(9):1084-91. doi: 10.1080/00365520903082432.

PMID:
19572232

Supplemental Content

Support Center